Pegasus Partners’s Novartis NVS Stock Holding History

Pegasus Partners’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,530	Closed	-$208K	–	98
2015 Q3	$208K	Hold	2,530	–	–	0.12%	80
2015 Q2	$223K	Buy	+2,530	New	+$232K	0.1%	89

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

Pegasus Partners's NVS Position: Q4 2015 in Review

Pegasus Partners sold out of Novartis (NVS) in Q4 2015, closing a stake of 2,530 shares — an estimated $208K sold.

Pegasus Partners first reported a position in NVS in Q2 2015 and held it in 2 quarters. The position peaked at $223K in Q2 2015. 926 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

Pegasus Partners reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
Pegasus Partners sold 2,530 Novartis shares in Q4 2015, an estimated $208K.
Pegasus Partners first reported a position in Novartis in Q2 2015 and held it in 2 quarters.
Pegasus Partners's Novartis position peaked at $223K in Q2 2015.
926 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on Pegasus Partners's 13F filing for Q4 2015, filed 8 Jan 2016.